Methylpyrrolopyrimidinecarboxamides

US8927557B2 · kind B2 · utility

Assignee

• TAKEDA GMBH · DE

Inventors

• Josef Stadlwieser · Konstanz, DE
• Beate Schmidt · Allensbach, DE
• Heiko Bernsmann · Frankfurt, DE
• Torsten Dunkern · Refrath, DE
• Ewald Benediktus · Biberach, DE
• Andreas Pahl · Ahrensburg, DE
• Ragna Hussong · Deißlingen, DE
• Olaf Nimz · Konstanz, DE
• Matthias Mueller · Konstanz, DE
• Martin Viertelhaus · Konstanz, DE

Key dates

• Filing date: Aug 24, 2010
• Grant date: Jan 6, 2015
• Expiry date: Nov 6, 2030

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P43/00
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The compounds of Formula (I),wherein R1, R2, R21, R22, R23, R24, Y and R3 have the meanings as given in the description, the salts thereof, the stereoisomers of the compounds and the salts thereof are effective inhibitors of the type 5 phosphodiesterase.